Analysis of C-MYC function in normal cells via conditional gene-targeted mutation

被引:330
作者
de Alboran, IM
O'Hagan, RC
Gärtner, F
Malynn, B
Davidson, L
Rickert, R
Rajewsky, K
DePinho, RA
Alt, FW [1 ]
机构
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Ctr Blood Res, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[4] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA
[5] Univ Cologne, Inst Genet, D-50931 Cologne, Germany
[6] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA
关键词
D O I
10.1016/S1074-7613(01)00088-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Germline inactivation of c-myc in mice causes embryonic lethality. Therefore, we developed a LoxP/Cre-based conditional mutation approach to test the role of c-myc in mouse embryonic fibroblasts (MEFs) and mature B lymphocytes. Cre expression resulted in reduced proliferation of wild-type MEFs, but c-Myc-deficient MEFs showed a further reduction. In contrast to fibroblasts, Cre expression had no apparent affect on wild-type B cell proliferation. Deletion of both c-Myc genes in B cells led to severely impaired proliferation in response to anti-CD40 plus IL-4. However, treated cells did upregulate several early activation markers but not CD95 or CD95 ligand. We discuss these findings with respect to potential c-Myc functions in proliferation and apoptosis and also discuss potential limitations in the Cre-mediated gene inactivation approach.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 60 条
  • [1] THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE
    ADAMS, JM
    HARRIS, AW
    PINKERT, CA
    CORCORAN, LM
    ALEXANDER, WS
    CORY, S
    PALMITER, RD
    BRINSTER, RL
    [J]. NATURE, 1985, 318 (6046) : 533 - 538
  • [2] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [3] ETOPOSIDE - CURRENT STATUS AND FUTURE PERSPECTIVES IN THE MANAGEMENT OF MALIGNANT NEOPLASMS
    BELANI, CP
    DOYLE, LA
    AISNER, J
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 : S118 - S126
  • [4] Repression of c-Myc responsive genes in cycling cells causes G(1) arrest through reduction of cyclin E CDK2 kinase activity
    Berns, K
    Hijmans, EM
    Bernards, R
    [J]. ONCOGENE, 1997, 15 (11) : 1347 - 1356
  • [5] Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
    Bouchard, C
    Thieke, K
    Maier, A
    Saffrich, R
    Hanley-Hyde, J
    Ansorge, W
    Reed, S
    Sicinski, P
    Bartek, J
    Eilers, M
    [J]. EMBO JOURNAL, 1999, 18 (19) : 5321 - 5333
  • [6] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BRUNNER, T
    MOGIL, RJ
    LAFACE, D
    YOO, NJ
    MAHBOUBI, A
    ECHEVERRI, F
    MARTIN, SJ
    FORCE, WR
    LYNCH, DH
    WARE, CF
    GREEN, DR
    [J]. NATURE, 1995, 373 (6513) : 441 - 444
  • [7] CELL-CYCLE CONTROL OF C-MYC BUT NOT C-RAS EXPRESSION IS LOST FOLLOWING CHEMICAL TRANSFORMATION
    CAMPISI, J
    GRAY, HE
    PARDEE, AB
    DEAN, M
    SONENSHEIN, GE
    [J]. CELL, 1984, 36 (02) : 241 - 247
  • [8] DAKSIS JI, 1994, ONCOGENE, V9, P3635
  • [9] A NULL C-MYC MUTATION CAUSES LETHALITY BEFORE 10.5 DAYS OF GESTATION IN HOMOZYGOTES AND REDUCED FERTILITY IN HETEROZYGOUS FEMALE MICE
    DAVIS, AC
    WIMS, M
    SPOTTS, GD
    HANN, SR
    BRADLEY, A
    [J]. GENES & DEVELOPMENT, 1993, 7 (04) : 671 - 682
  • [10] CLONING AND CHARACTERIZATION OF DIFFERENT HUMAN SEQUENCES RELATED TO THE ONC GENE (V-MYC) OF AVIAN MYELOCYTOMATOSIS VIRUS (MC29)
    DELLAFAVERA, R
    GELMANN, EP
    MARTINOTTI, S
    FRANCHINI, G
    PAPAS, TS
    GALLO, RC
    WONGSTAAL, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (21): : 6497 - 6501